 NMDA antagonists antiparkinsonian actions L-dopa monoamine-depleted rats N-methyl-D-aspartate NMDA maleate CPP ability L-dopa akinesia muscular rigidity monoamine-depleted rats basis findings NMDA antagonists beneficial adjunctive treatment therapy Parkinson disease CPP subthalamic nucleus entopeduncular nucleus rat homologue internal pallidal segment substantia nigra pars reticulata monoamine-depleted rats locomotor activity rigidity whereas local microinjection CPP neostriatum ineffective results unlikely neostriatum site antiparkinsonian action NMDA antagonists monoamine-depleted rats subthalamic nucleus internal pallidal segment substantia nigra pars important effects NMDA antagonists